Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11110935rdf:typepubmed:Citationlld:pubmed
pubmed-article:11110935lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C0011923lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C0046056lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C0596545lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1980023lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1979874lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1513743lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C0205087lld:lifeskim
pubmed-article:11110935lifeskim:mentionsumls-concept:C1627358lld:lifeskim
pubmed-article:11110935pubmed:issue3lld:pubmed
pubmed-article:11110935pubmed:dateCreated2001-1-2lld:pubmed
pubmed-article:11110935pubmed:abstractTextTo combine three magnetic resonance (MR) imaging modalities-dobutamine stress cine, first pass, and late contrast material-enhanced T1-weighted imaging-and to compare the results with 2-[fluorine 18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) in the assessment of unviable myocardium in coronary artery disease.lld:pubmed
pubmed-article:11110935pubmed:languageenglld:pubmed
pubmed-article:11110935pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11110935pubmed:citationSubsetAIMlld:pubmed
pubmed-article:11110935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11110935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11110935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11110935pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11110935pubmed:statusMEDLINElld:pubmed
pubmed-article:11110935pubmed:monthDeclld:pubmed
pubmed-article:11110935pubmed:issn0033-8419lld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:HänninenHHlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:NiemiPPlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:MäkeläTTlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:ToivonenLLlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:AronenH JHJlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:Voipio-Pulkki...lld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:KnuutiJJlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:LauermaKKlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:JanatuinenTTlld:pubmed
pubmed-article:11110935pubmed:authorpubmed-author:MäkijärviM...lld:pubmed
pubmed-article:11110935pubmed:issnTypePrintlld:pubmed
pubmed-article:11110935pubmed:volume217lld:pubmed
pubmed-article:11110935pubmed:ownerNLMlld:pubmed
pubmed-article:11110935pubmed:authorsCompleteYlld:pubmed
pubmed-article:11110935pubmed:pagination729-36lld:pubmed
pubmed-article:11110935pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:meshHeadingpubmed-meshheading:11110935...lld:pubmed
pubmed-article:11110935pubmed:year2000lld:pubmed
pubmed-article:11110935pubmed:articleTitleMultimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience.lld:pubmed
pubmed-article:11110935pubmed:affiliationDepts of Radiology and Medicine, Helsinki University Central Hospital (HUCH), Haartmaninkatu 4, 00029 Helsinki, Finland. kirsi.lauerma@hus.filld:pubmed
pubmed-article:11110935pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11110935pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11110935lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11110935lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11110935lld:pubmed